Publications by authors named "Kerstin Buck"

Claim this Profile
T
Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein.
Natalie Landeck, Katherine E Strathearn, Daniel Ysselstein, Kerstin Buck, Sayan Dutta

Mol Neurodegener· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxic effects of human and rodent variants of alpha-synuclein in vivo.
Natalie Landeck, Kerstin Buck, Deniz Kirik

Eur J Neurosci· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of brain metabolite correlates of adeno-associated virus-mediated over-expression of human alpha-synuclein in cortical neurons by in vivo (1) H-MR spectroscopy at 9.4 T.
Sandra Cuellar-Baena, Natalie Landeck, Sarah Sonnay, Kerstin Buck, Vladimir Mlynarik

J Neurochem· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.
Kerstin Buck, Natalie Landeck, Ayse Ulusoy, Nour K Majbour, Omar M A El-Agnaf

Neurobiol Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neurons.
Ayse Ulusoy, Tomas Björklund, Kerstin Buck, Deniz Kirik

Neurobiol Dis· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L-DOPA-induced dyskinesia in Parkinson's disease: a drug discovery perspective.
Kerstin Buck, Boris Ferger

Drug Discov Today· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous dopaminergic stimulation by pramipexole is effective to treat early morning akinesia in animal models of Parkinson's disease: A pharmacokinetic-pharmacodynamic study using in vivo microdialysis in rats.
Boris Ferger, Kerstin Buck, Makoto Shimasaki, Eliza Koros, Patrizia Voehringer

Synapse· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
Kerstin Buck, Boris Ferger

Synapse· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The alpha(2) adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.
Kerstin Buck, Patrizia Voehringer, Boris Ferger

J Neurochem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid analysis of GABA and glutamate in microdialysis samples using high performance liquid chromatography and tandem mass spectrometry.
Kerstin Buck, Patrizia Voehringer, Boris Ferger

J Neurosci Methods· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of levodopa on striatal monoamines in mice with levodopa-induced hyperactivity.
Anthony P Nicholas, Kerstin Buck, Boris Ferger

Neurosci Lett· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.
Kerstin Buck, Boris Ferger

Neurobiol Dis· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis